Dr. Elaine Trogdon, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 5912 Tall Branches Pass, Clarksville, MD 21029 Phone: 410-707-6069 Fax: 443-533-5987 |
Dr. Margaret Ellen Sears-dementhon, DO Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 6578 Guilford Rd, Clarksville, MD 21029 Phone: 301-854-1008 Fax: 301-854-0305 |
Dr. Jami Reyes, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 6016 Red Clover Ln, Clarksville, MD 21029 Phone: 410-531-6025 |
David Heppel, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 7318 Meadow Wood Way, Clarksville, MD 21029 Phone: 301-498-2881 |
News Archive
Cataract surgeries performed over one year eventually save $123.4 billion over 13 years and delivers a 4,567 percent financial return on investment to society according to the results of a cost-utility study, published online today in the Academy's official journal, Ophthalmology, and will be presented on Nov. 17 at the world's largest ophthalmic conference, the American Academy of Ophthalmology's 117th Annual Meeting, in New Orleans. Researchers say that the results prove that healthcare interventions create substantial economic wealth.
A new multinational study has reported a very full account of the B lymphocytes that produce group E antibodies, also called IgE (Immunoglobulin E), that are behind allergic reactions, which are common in up to a third of the world's population.
"My husband of thirty-five years passed away seven years ago, and I lost my daughter in a car accident last year, I honestly could no longer find the energy to smile or laugh," recounts sixty-year-old widow Opal Perry. "My son suggested I try a new hormone being touted to help with symptoms of depression, called oxytocin. After the second day I was driving and caught myself smiling in the mirror. I couldn't believe it. I had to do a double take. I hadn't really smiled in seven years! I thought I would never smile again until now."
Metabolex announced positive results from its clinical study of arhalofenate in combination with febuxostat. A key goal in the treatment of gout is to address the patient's underlying hyperuricemia by treatment with drugs that lower serum uric acid.
› Verified 5 days ago